Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Expert review of hematology · 2020
    MBMichal Bar-Natan Zommer
    PMID: 33012187PMCID: PMC8691658DOIFirst author2 citations

Publications

43 publications

Clinical research

2 studies

Active

1 study
  • PI
    Disease characteristics and outcomes of acute lymphoblastic leukemia (ALL) in adults with central nervous system (CNS) involvement
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
Completed & closed trials (1)
  • PI
    A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy
    PHASE3 · Children's Oncology Group · CLOSED TO ACCRUAL (as of 2026)
    B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; B Acute Lymphoblastic Leukemia, BCR-ABL1-Like; Lymphoblastic Lymphoma; Mixed Phenotype Acute Leukemia; T Acute Lymphoblastic Leukemia
    NCT05602194

External relationships

Advisory/Scientific Board Member

AstraZeneca, PLC